Validation of NRG oncology/RTOG‐0129 risk groups for...

  • Main
  • 2019 / 03
  • Validation of NRG oncology/RTOG‐0129 risk groups for...

Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials

Fakhry, Carole, Zhang, Qiang, Gillison, Maura L., Nguyen‐Tân, Phuc Felix, Rosenthal, David I., Weber, Randal S., Lambert, Louise, Trotti, Andy M., Barrett, William L., Thorstad, Wade L., Yom, Sue S.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer
DOI:
10.1002/cncr.32025
Date:
March, 2019
File:
PDF, 614 KB
2019
Conversion to is in progress
Conversion to is failed